Merger • Life Science

Pfizer Acquires Warner-Lambert Company

On February 8, 2000, Pfizer acquired life science company Warner-Lambert Company for 90.2B USD

Acquisition Context
  • This is Pfizer’s 1st transaction in the Life Science sector.
  • This is Pfizer’s largest (disclosed) transaction.
  • This is Pfizer’s 1st transaction in the United States.
  • This is Pfizer’s 1st transaction in New Jersey.

Explore All 191 Merger Life Science Deals - Search the Database Free


M&A Deal Summary

Date February 8, 2000
Target Warner-Lambert Company
Sector Life Science
Buyer(s) Pfizer
Deal Type Merger
Deal Value 90.2B USD

Target Company

Warner-Lambert Company

Morris Plains, New Jersey, United States
Warner–Lambert an American pharmaceutical company. The Company was formed in 1920 and was based in Morris Plains, New Jersey.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Pfizer

New York, New York, United States

Category Company
Founded 1849
Sector Life Science
Employees81,000
Revenue 63.6B USD (2024)
DESCRIPTION
Pfizer office in Lake Forest, Illinois.
Pfizer office in Lake Forest, Illinois.

Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.


Deal Context for Buyer #
Overall 1 of 46
Sector: Life Science 1 of 41
Type: Merger 1 of 2
State: New Jersey 1 of 3
Country: United States 1 of 33
Year: 2000 1 of 1
Size (of disclosed) 1 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1998-07-22 American Medical Systems

Minnetonka, Minnesota, United States

American Medical Systems, Inc. is a manufacturer and marketer of medical devices for the surgical treatment of urological and gynecological disorders.

Sell $130M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2002-11-06 Tetra

Melle, Germany

Producer of aquatic pet food.

Sell $238M